Literature DB >> 25024430

Targeting cancer stem cell plasticity through modulation of epidermal growth factor and insulin-like growth factor receptor signaling in head and neck squamous cell cancer.

Hui Sun Leong1, Fui Teen Chong1, Pui Hoon Sew1, Dawn P Lau1, Bernice H Wong1, Bin-Tean Teh1, Daniel S W Tan2, N Gopalakrishna Iyer2.   

Abstract

Emerging data suggest that cancer stem cells (CSCs) exist in equilibrium with differentiated cells and that stochastic transitions between these states can account for tumor heterogeneity and drug resistance. The aim of this study was to establish an in vitro system that recapitulates stem cell plasticity in head and neck squamous cell cancers (HNSCCs) and identify the factors that play a role in the maintenance and repopulation of CSCs. Tumor spheres were established using patient-derived cell lines via anchorage-independent cell culture techniques. These tumor spheres were found to have higher aldehyde dehydrogenase (ALD) cell fractions and increased expression of Kruppel-like factor 4, SRY (sex determining region Y)-box 2, and Nanog and were resistant to γ-radiation, 5-fluorouracil, cisplatin, and etoposide treatment compared with monolayer culture cells. Monolayer cultures were subject to single cell cloning to generate clones with high and low ALD fractions. ALDHigh clones showed higher expression of stem cell and epithelial-mesenchymal transition markers compared with ALDLow clones. ALD fractions, representing stem cell fractions, fluctuated with serial passaging, equilibrating at a level specific to each cell line, and could be augmented by the addition of epidermal growth factor (EGF) and/or insulin. ALDHigh clones showed increased EGF receptor (EGFR) and insulin-like growth factor-1 receptor (IGF-1R) phosphorylation, with increased activation of downstream pathways compared with ALDLow clones. Importantly, blocking these pathways using specific inhibitors against EGFR and IGF-1R reduced stem cell fractions drastically. Taken together, these results show that HNSCC CSCs exhibit plasticity, with the maintenance of the stem cell fraction dependent on the EGFR and IGF-1R pathways and potentially amenable to targeted therapeutics. ©AlphaMed Press.

Entities:  

Keywords:  Aldehyde dehydrogenase; Cancer stem cell; Epidermal growth factor receptor; Head and neck squamous cell cancer; Insulin-like growth factor-1 receptor

Mesh:

Substances:

Year:  2014        PMID: 25024430      PMCID: PMC4149297          DOI: 10.5966/sctm.2013-0214

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  32 in total

Review 1.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

Review 2.  Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.

Authors:  Jan Paul Medema; Louis Vermeulen
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

3.  Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer.

Authors:  Julia Y S Tsang; Yu-Hua Huang; Ming-Hua Luo; Yun-Bi Ni; Siu-Ki Chan; Philip C W Lui; Alex M C Yu; Puay Hoon Tan; Gary M Tse
Journal:  Breast Cancer Res Treat       Date:  2012-09-30       Impact factor: 4.872

4.  Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Authors:  S Schmitz; M-C Kaminsky-Forrett; S Henry; S Zanetta; L Geoffrois; E Bompas; A Moxhon; L Mignion; J Guigay; L Knoops; M Hamoir; J-P Machiels
Journal:  Ann Oncol       Date:  2012-01-10       Impact factor: 32.976

5.  Epidermal growth factor receptor variant III contributes to cancer stem cell phenotypes in invasive breast carcinoma.

Authors:  Catherine A Del Vecchio; Kristin C Jensen; Ryan T Nitta; A Hunter Shain; Craig P Giacomini; Albert J Wong
Journal:  Cancer Res       Date:  2012-03-14       Impact factor: 12.701

6.  Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.

Authors:  Peter S Hammerman; Pasi A Jänne; Bruce E Johnson
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

7.  Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes.

Authors:  Ping Zhang; Yan Zhang; Li Mao; Zhiyuan Zhang; Wantao Chen
Journal:  Cancer Lett       Date:  2009-01-30       Impact factor: 8.679

8.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Authors:  Christophe Ginestier; Min Hee Hur; Emmanuelle Charafe-Jauffret; Florence Monville; Julie Dutcher; Marty Brown; Jocelyne Jacquemier; Patrice Viens; Celina G Kleer; Suling Liu; Anne Schott; Dan Hayes; Daniel Birnbaum; Max S Wicha; Gabriela Dontu
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

9.  Kruppel-like factor 5 modulates p53-independent apoptosis through Pim1 survival kinase in cancer cells.

Authors:  Y Zhao; M S Hamza; H S Leong; C-B Lim; Y-F Pan; E Cheung; K-C Soo; N G Iyer
Journal:  Oncogene       Date:  2007-07-02       Impact factor: 9.867

10.  Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.

Authors:  Chao Chen; Yan Wei; Michael Hummel; Thomas K Hoffmann; Manfred Gross; Andreas M Kaufmann; Andreas E Albers
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

View more
  11 in total

1.  Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.

Authors:  Rui Chen; Ge Jin; Wei Li; Thomas M McIntyre
Journal:  J Immunol       Date:  2018-08-27       Impact factor: 5.422

2.  Anti-EGFR treatment effects on laryngeal cancer stem cells.

Authors:  Glaucia Maria de Mendonça Fernandes; Ana Lívia Silva Galbiatti-Dias; Leticia Antunes Muniz Ferreira; Vilson Serafim Junior; Gabriela Helena Rodrigues-Fleming; Juliana Garcia de Oliveira-Cucolo; Patrícia Matos Biselli-Chicote; Rosa Sayoko Kawasaki-Oyama; José Victor Maniglia; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

3.  Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma.

Authors:  Daniel S W Tan; Fui Teen Chong; Hui Sun Leong; Shen Yon Toh; Dawn P Lau; Xue Lin Kwang; Xiaoqian Zhang; Gopinath M Sundaram; Gek San Tan; Mei Mei Chang; Boon Tin Chua; Wan Teck Lim; Eng Huat Tan; Mei Kim Ang; Tony K H Lim; Prabha Sampath; Balram Chowbay; Anders J Skanderup; Ramanuj DasGupta; N Gopalakrishna Iyer
Journal:  Nat Med       Date:  2017-09-18       Impact factor: 53.440

4.  Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling.

Authors:  Yulyana Yulyana; Ivy A W Ho; Kian Chuan Sia; Jennifer P Newman; Xin Yi Toh; Berwini B Endaya; Jerry K Y Chan; Massimiliano Gnecchi; Hung Huynh; Alexander Y F Chung; Kiat Hon Lim; Hui Sun Leong; Narayanan Gopalakrishna Iyer; Kam Man Hui; Paula Y P Lam
Journal:  Mol Ther       Date:  2015-01-26       Impact factor: 11.454

5.  Tongue carcinoma infrequently harbor common actionable genetic alterations.

Authors:  Daniel S W Tan; Weining Wang; Hui Sun Leong; Pui Hoon Sew; Dawn P Lau; Fui Teen Chong; Sai Sakktee Krisna; Tony K H Lim; N Gopalakrishna Iyer
Journal:  BMC Cancer       Date:  2014-09-19       Impact factor: 4.430

6.  Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.

Authors:  Sara Duhachek-Muggy; Yue Qi; Randi Wise; Linda Alyahya; Hui Li; Jacob Hodge; Anna Zolkiewska
Journal:  Mol Cancer       Date:  2017-02-01       Impact factor: 27.401

7.  GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers.

Authors:  Suhail Ahmed Kabeer Rasheed; Hui Sun Leong; Manikandan Lakshmanan; Anandhkumar Raju; Dhivya Dadlani; Fui-Teen Chong; Nicholas B Shannon; Ravisankar Rajarethinam; Thakshayeni Skanthakumar; Ern Yu Tan; Jacqueline Siok Gek Hwang; Kok Hing Lim; Daniel Shao-Weng Tan; Paolo Ceppi; Mei Wang; Vinay Tergaonkar; Patrick J Casey; N Gopalakrishna Iyer
Journal:  Oncogene       Date:  2017-12-19       Impact factor: 9.867

8.  Cancer stem cells-driven tumor growth and immune escape: the Janus face of neurotrophins.

Authors:  Viviana Triaca; Valentina Carito; Elena Fico; Pamela Rosso; Marco Fiore; Massimo Ralli; Alessandro Lambiase; Antonio Greco; Paola Tirassa
Journal:  Aging (Albany NY)       Date:  2019-12-07       Impact factor: 5.682

Review 9.  Ex Vivo Culture Models to Indicate Therapy Response in Head and Neck Squamous Cell Carcinoma.

Authors:  Imke Demers; Johan Donkers; Bernd Kremer; Ernst Jan Speel
Journal:  Cells       Date:  2020-11-23       Impact factor: 6.600

Review 10.  Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.

Authors:  Amy J C Dohmen; Justin E Swartz; Michiel W M Van Den Brekel; Stefan M Willems; René Spijker; Jacques Neefjes; Charlotte L Zuur
Journal:  Cancers (Basel)       Date:  2015-08-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.